Journal of Clinical Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向：临床医学 经验分享：Pending editor decision十天了，不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=915525, encodeId=dd7e915525e2, content=辣鸡杂志，只要有中国人的名字就秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ac5340342, createdName=ms9000002107544139, createdTime=Mon Jan 11 10:47:27 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127231, encodeId=f259212e231ba, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Thu Apr 20 12:36:32 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2126080, encodeId=3d5321260805e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：拒稿很快 desk reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8795314350, createdName=宇智波佐助, createdTime=Sat Apr 15 15:29:16 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110721, encodeId=ae082110e215e, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：前列腺癌;protocol 经验分享：1月14号，17号拒，国人很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8de5519428, createdName=sally888, createdTime=Wed Jan 18 14:24:56 CST 2023, time=2023-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108695, encodeId=e99e21086959f, content=这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e25400595, createdName=liuniu, createdTime=Tue Jan 03 22:05:39 CST 2023, time=2023-01-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1236832, encodeId=f9d712368324b, content=收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Fri Aug 05 20:31:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101478, encodeId=1e8f21014e8d8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sat Nov 19 11:36:07 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向：临床医学 经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106176, encodeId=7dfc21061e639, content=发来一份邀稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Thu Dec 15 13:20:24 CST 2022, time=2022-12-15, status=1, ipAttribution=四川省)]

2023-01-11 ms2000001239602400 来自上海

偏重的研究方向：临床医学
经验分享：Pending editor decision十天了，不知道多久能有结果。

115 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向：临床医学 经验分享：Pending editor decision十天了，不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=915525, encodeId=dd7e915525e2, content=辣鸡杂志，只要有中国人的名字就秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ac5340342, createdName=ms9000002107544139, createdTime=Mon Jan 11 10:47:27 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127231, encodeId=f259212e231ba, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Thu Apr 20 12:36:32 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2126080, encodeId=3d5321260805e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：拒稿很快 desk reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8795314350, createdName=宇智波佐助, createdTime=Sat Apr 15 15:29:16 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110721, encodeId=ae082110e215e, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：前列腺癌;protocol 经验分享：1月14号，17号拒，国人很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8de5519428, createdName=sally888, createdTime=Wed Jan 18 14:24:56 CST 2023, time=2023-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108695, encodeId=e99e21086959f, content=这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e25400595, createdName=liuniu, createdTime=Tue Jan 03 22:05:39 CST 2023, time=2023-01-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1236832, encodeId=f9d712368324b, content=收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Fri Aug 05 20:31:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101478, encodeId=1e8f21014e8d8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sat Nov 19 11:36:07 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向：临床医学 经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106176, encodeId=7dfc21061e639, content=发来一份邀稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Thu Dec 15 13:20:24 CST 2022, time=2022-12-15, status=1, ipAttribution=四川省)]

2021-01-11 ms9000002107544139

辣鸡杂志，只要有中国人的名字就秒拒

237 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向：临床医学 经验分享：Pending editor decision十天了，不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=915525, encodeId=dd7e915525e2, content=辣鸡杂志，只要有中国人的名字就秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ac5340342, createdName=ms9000002107544139, createdTime=Mon Jan 11 10:47:27 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127231, encodeId=f259212e231ba, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Thu Apr 20 12:36:32 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2126080, encodeId=3d5321260805e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：拒稿很快 desk reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8795314350, createdName=宇智波佐助, createdTime=Sat Apr 15 15:29:16 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110721, encodeId=ae082110e215e, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：前列腺癌;protocol 经验分享：1月14号，17号拒，国人很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8de5519428, createdName=sally888, createdTime=Wed Jan 18 14:24:56 CST 2023, time=2023-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108695, encodeId=e99e21086959f, content=这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e25400595, createdName=liuniu, createdTime=Tue Jan 03 22:05:39 CST 2023, time=2023-01-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1236832, encodeId=f9d712368324b, content=收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Fri Aug 05 20:31:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101478, encodeId=1e8f21014e8d8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sat Nov 19 11:36:07 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向：临床医学 经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106176, encodeId=7dfc21061e639, content=发来一份邀稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Thu Dec 15 13:20:24 CST 2022, time=2022-12-15, status=1, ipAttribution=四川省)]

2023-04-20 拉丁神曲来自陕西省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：临床医学
经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投

87 0

[GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向：临床医学 经验分享：Pending editor decision十天了，不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=915525, encodeId=dd7e915525e2, content=辣鸡杂志，只要有中国人的名字就秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ac5340342, createdName=ms9000002107544139, createdTime=Mon Jan 11 10:47:27 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127231, encodeId=f259212e231ba, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Thu Apr 20 12:36:32 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2126080, encodeId=3d5321260805e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：拒稿很快 desk reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8795314350, createdName=宇智波佐助, createdTime=Sat Apr 15 15:29:16 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110721, encodeId=ae082110e215e, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：前列腺癌;protocol 经验分享：1月14号，17号拒，国人很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8de5519428, createdName=sally888, createdTime=Wed Jan 18 14:24:56 CST 2023, time=2023-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108695, encodeId=e99e21086959f, content=这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e25400595, createdName=liuniu, createdTime=Tue Jan 03 22:05:39 CST 2023, time=2023-01-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1236832, encodeId=f9d712368324b, content=收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Fri Aug 05 20:31:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101478, encodeId=1e8f21014e8d8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sat Nov 19 11:36:07 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向：临床医学 经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106176, encodeId=7dfc21061e639, content=发来一份邀稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Thu Dec 15 13:20:24 CST 2022, time=2022-12-15, status=1, ipAttribution=四川省)]

2023-04-15 宇智波佐助

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：临床医学
经验分享：拒稿很快 desk reject

64 0

[GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向：临床医学 经验分享：Pending editor decision十天了，不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=915525, encodeId=dd7e915525e2, content=辣鸡杂志，只要有中国人的名字就秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ac5340342, createdName=ms9000002107544139, createdTime=Mon Jan 11 10:47:27 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127231, encodeId=f259212e231ba, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Thu Apr 20 12:36:32 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2126080, encodeId=3d5321260805e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：拒稿很快 desk reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8795314350, createdName=宇智波佐助, createdTime=Sat Apr 15 15:29:16 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110721, encodeId=ae082110e215e, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：前列腺癌;protocol 经验分享：1月14号，17号拒，国人很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8de5519428, createdName=sally888, createdTime=Wed Jan 18 14:24:56 CST 2023, time=2023-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108695, encodeId=e99e21086959f, content=这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e25400595, createdName=liuniu, createdTime=Tue Jan 03 22:05:39 CST 2023, time=2023-01-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1236832, encodeId=f9d712368324b, content=收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Fri Aug 05 20:31:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101478, encodeId=1e8f21014e8d8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sat Nov 19 11:36:07 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向：临床医学 经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106176, encodeId=7dfc21061e639, content=发来一份邀稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Thu Dec 15 13:20:24 CST 2022, time=2022-12-15, status=1, ipAttribution=四川省)]

2023-01-18 sally888 来自江苏省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：前列腺癌;protocol
经验分享：1月14号，17号拒，国人很难投

79 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向：临床医学 经验分享：Pending editor decision十天了，不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=915525, encodeId=dd7e915525e2, content=辣鸡杂志，只要有中国人的名字就秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ac5340342, createdName=ms9000002107544139, createdTime=Mon Jan 11 10:47:27 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127231, encodeId=f259212e231ba, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Thu Apr 20 12:36:32 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2126080, encodeId=3d5321260805e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：拒稿很快 desk reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8795314350, createdName=宇智波佐助, createdTime=Sat Apr 15 15:29:16 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110721, encodeId=ae082110e215e, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：前列腺癌;protocol 经验分享：1月14号，17号拒，国人很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8de5519428, createdName=sally888, createdTime=Wed Jan 18 14:24:56 CST 2023, time=2023-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108695, encodeId=e99e21086959f, content=这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e25400595, createdName=liuniu, createdTime=Tue Jan 03 22:05:39 CST 2023, time=2023-01-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1236832, encodeId=f9d712368324b, content=收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Fri Aug 05 20:31:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101478, encodeId=1e8f21014e8d8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sat Nov 19 11:36:07 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向：临床医学 经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106176, encodeId=7dfc21061e639, content=发来一份邀稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Thu Dec 15 13:20:24 CST 2022, time=2022-12-15, status=1, ipAttribution=四川省)]

2023-01-03 liuniu 来自安徽省

这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？

103 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向：临床医学 经验分享：Pending editor decision十天了，不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=915525, encodeId=dd7e915525e2, content=辣鸡杂志，只要有中国人的名字就秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ac5340342, createdName=ms9000002107544139, createdTime=Mon Jan 11 10:47:27 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127231, encodeId=f259212e231ba, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Thu Apr 20 12:36:32 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2126080, encodeId=3d5321260805e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：拒稿很快 desk reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8795314350, createdName=宇智波佐助, createdTime=Sat Apr 15 15:29:16 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110721, encodeId=ae082110e215e, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：前列腺癌;protocol 经验分享：1月14号，17号拒，国人很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8de5519428, createdName=sally888, createdTime=Wed Jan 18 14:24:56 CST 2023, time=2023-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108695, encodeId=e99e21086959f, content=这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e25400595, createdName=liuniu, createdTime=Tue Jan 03 22:05:39 CST 2023, time=2023-01-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1236832, encodeId=f9d712368324b, content=收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Fri Aug 05 20:31:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101478, encodeId=1e8f21014e8d8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sat Nov 19 11:36:07 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向：临床医学 经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106176, encodeId=7dfc21061e639, content=发来一份邀稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Thu Dec 15 13:20:24 CST 2022, time=2022-12-15, status=1, ipAttribution=四川省)]

2022-08-05 wanderer2019

收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么

118 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向：临床医学 经验分享：Pending editor decision十天了，不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=915525, encodeId=dd7e915525e2, content=辣鸡杂志，只要有中国人的名字就秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ac5340342, createdName=ms9000002107544139, createdTime=Mon Jan 11 10:47:27 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127231, encodeId=f259212e231ba, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Thu Apr 20 12:36:32 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2126080, encodeId=3d5321260805e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：拒稿很快 desk reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8795314350, createdName=宇智波佐助, createdTime=Sat Apr 15 15:29:16 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110721, encodeId=ae082110e215e, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：前列腺癌;protocol 经验分享：1月14号，17号拒，国人很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8de5519428, createdName=sally888, createdTime=Wed Jan 18 14:24:56 CST 2023, time=2023-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108695, encodeId=e99e21086959f, content=这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e25400595, createdName=liuniu, createdTime=Tue Jan 03 22:05:39 CST 2023, time=2023-01-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1236832, encodeId=f9d712368324b, content=收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Fri Aug 05 20:31:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101478, encodeId=1e8f21014e8d8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sat Nov 19 11:36:07 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向：临床医学 经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106176, encodeId=7dfc21061e639, content=发来一份邀稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Thu Dec 15 13:20:24 CST 2022, time=2022-12-15, status=1, ipAttribution=四川省)]

2022-11-19 ms5000000019231764

审稿速度:1.0 | 投稿命中率:5.0
经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your
submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work.

97 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向：临床医学 经验分享：Pending editor decision十天了，不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=915525, encodeId=dd7e915525e2, content=辣鸡杂志，只要有中国人的名字就秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ac5340342, createdName=ms9000002107544139, createdTime=Mon Jan 11 10:47:27 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127231, encodeId=f259212e231ba, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Thu Apr 20 12:36:32 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2126080, encodeId=3d5321260805e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：拒稿很快 desk reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8795314350, createdName=宇智波佐助, createdTime=Sat Apr 15 15:29:16 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110721, encodeId=ae082110e215e, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：前列腺癌;protocol 经验分享：1月14号，17号拒，国人很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8de5519428, createdName=sally888, createdTime=Wed Jan 18 14:24:56 CST 2023, time=2023-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108695, encodeId=e99e21086959f, content=这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e25400595, createdName=liuniu, createdTime=Tue Jan 03 22:05:39 CST 2023, time=2023-01-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1236832, encodeId=f9d712368324b, content=收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Fri Aug 05 20:31:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101478, encodeId=1e8f21014e8d8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sat Nov 19 11:36:07 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向：临床医学 经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106176, encodeId=7dfc21061e639, content=发来一份邀稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Thu Dec 15 13:20:24 CST 2022, time=2022-12-15, status=1, ipAttribution=四川省)]

2022-07-29 lancet1111

偏重的研究方向：临床医学
经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧

232 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2109807, encodeId=21a7210980e45, content=偏重的研究方向：临床医学 经验分享：Pending editor decision十天了，不知道多久能有结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e68e5508088, createdName=ms2000001239602400, createdTime=Wed Jan 11 12:49:10 CST 2023, time=2023-01-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=915525, encodeId=dd7e915525e2, content=辣鸡杂志，只要有中国人的名字就秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6ac5340342, createdName=ms9000002107544139, createdTime=Mon Jan 11 10:47:27 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127231, encodeId=f259212e231ba, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：MDPI旗下杂志，如果能送外审基本95%能中，但大部分文章都止步在第一步，对中国医院的文章形式审查比较严格，文章要求的工作量和创新性都不低，并不容易投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG579482BEDC45A6198.jpg, createdBy=5f031707869, createdName=拉丁神曲, createdTime=Thu Apr 20 12:36:32 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2126080, encodeId=3d5321260805e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床医学 经验分享：拒稿很快 desk reject, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f8795314350, createdName=宇智波佐助, createdTime=Sat Apr 15 15:29:16 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110721, encodeId=ae082110e215e, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：前列腺癌;protocol 经验分享：1月14号，17号拒，国人很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8de5519428, createdName=sally888, createdTime=Wed Jan 18 14:24:56 CST 2023, time=2023-01-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108695, encodeId=e99e21086959f, content=这个期刊是不是不收单位是中国医院的文章啊？整个MDPI旗下期刊是不是都是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34e25400595, createdName=liuniu, createdTime=Tue Jan 03 22:05:39 CST 2023, time=2023-01-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1236832, encodeId=f9d712368324b, content=收到JCM的Call for Paper，看评论前两年国人投稿常常被秒拒，现在这操作是因为没有中国人投稿了么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epL9UYaTtbQNaicUzJ8pBH0HkAa2MYghXkGNafOLKUou4xZa5yM0iaZrxaM0J50uhUO7uzfw36CMxzg/132, createdBy=5fb72240025, createdName=wanderer2019, createdTime=Fri Aug 05 20:31:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101478, encodeId=1e8f21014e8d8, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：拒稿效率很高，头天投的，第二天就拒了，拒稿理由：We are writing to inform you that we will not be able to process your submission further. Submissions sent for peer-review are selected on the basis of discipline, novelty and general significance, in addition to the usual criteria for publication in scholarly journals. Therefore, our decision is not necessarily a reflection of the quality of your work., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e8349335, createdName=ms5000000019231764, createdTime=Sat Nov 19 11:36:07 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235456, encodeId=fe12123545609, content=偏重的研究方向：临床医学 经验分享：投稿第二天有幸under review了，还没有秒拒，希望有好结果吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Fri Jul 29 12:54:18 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106176, encodeId=7dfc21061e639, content=发来一份邀稿…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42295203971, createdName=翊翊翊, createdTime=Thu Dec 15 13:20:24 CST 2022, time=2022-12-15, status=1, ipAttribution=四川省)]

2022-12-15 翊翊翊来自四川省

发来一份邀稿…

74 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务